Novartis gets EU approval for potential blockbuster cholesterol drug Leqvio | ReutersZURICH (Reuters)

Novartis said on Friday it received approval from the European Commission for Leqvio, also known as inclisiran, a drug to lower cholesterol that the Swiss drugmaker bought last year in a deal worth nearly $10 billion and expects to be a top seller.#manchesterunited#HealthForAll#HealthBroadcastingService#GlobalHealth#Covid-19#coronavirus#Health#paulpogba#ukcoronavirus#HealthBroadcastingServiceInPublicHealthPartnership#rochellewalensky#timespersonoftheyear#paulmccartney#sevillavsrealmadrid#spotify2020#joeanderson#extraterrestriallife#vaccine#davidllander#paolorossi#kidcudi#elitedangerous#chelseavsleedsunited#bobingen#euromillions#softbank#ncis#capitalpunishment#juventusfc#goldiehawn#worldhealthorganisation#saturdaynightlivehttps://uk.reuters.com/…/novartis-cholesterol…